New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

Researchers have developed a new imaging-based technique for removing arterial plaque in patients with atherosclerosis, presenting their findings at the 182nd Meeting of the Acoustical Society of America (ASA).

The team’s method includes a low-power laser that works together with ultrasound technology. The pulsed laser created microbubbles, they explained, and sound waves from the ultrasound expands and collapses the microbubbles, using cavitation to mechanically break down the plaque.

“In conventional laser angioplasty, a high laser power is required for the entire cavitation process, whereas in our technology, a lower laser power is only required for initiating the cavitation process,” Rohit Singh, a PhD student with the University of Kansas Institute for Bioengineering Research, said in a statement. “Overall, the combination of ultrasound and laser reduces the need for laser power and improves the efficiency of atherosclerotic plaque removal.”

This technique was also designed to reduce the risk of restenosis, dissection or perforation.

This technology is still in the development phase, with in vivo studies expected to begin in the near future. Singh et al. hope to use this same method to treat other conditions, including ultrasound-assisted endovascular laser thrombolysis.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.